SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-011838
Filing Date
2023-04-11
Accepted
2023-04-11 16:30:36
Documents
12
Period of Report
2023-04-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 33899
  Complete submission text file 0001493152-23-011838.txt   208012

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20230406_lab.xml EX-101.LAB 34240
3 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20230406_pre.xml EX-101.PRE 22379
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20230406.xsd EX-101.SCH 3257
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3597
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 23813711
SIC: 2834 Pharmaceutical Preparations